Comedian Cedric the Entertainer stars in The American Diabetes Association's latest commercial titled 'Step On Up.' Addressing that chronic nerve pain is no laughing matter, the celebrity tells viewers suffering from pain that makes ordinary tasks extraordinarily painful "I hear you."
Ending the commercial with a personal anecdote about his father -- who he watched suffer from chronic nerve pain for years -- Cedric the Entertainer urges those with diabetes to get treatment and suggests that avoiding professional help can make the problem increasingly worse over time.
The American Diabetes Association's 'Step On Up' ad explores chronic nerve pain while encouraging diabetes patients to address their difficulties instead of ignoring them -- an occurrence that can happen way too often among those who choose to power through the pain instead of treating it.
Celeb-Endorsed Diabetes Ads
The American Diabetes Association's Latest Ad Encourages Treatment
Trend Themes
1. Celeb-endorsed Diabetes Ads - Disruptive innovation opportunity: Leveraging celebrity endorsements to increase awareness and encourage treatment for chronic nerve pain among diabetes patients.
2. Addressing Chronic Nerve Pain - Disruptive innovation opportunity: Developing innovative treatments and solutions for chronic nerve pain in diabetes patients to improve their quality of life.
3. Encouraging Diabetes Treatment - Disruptive innovation opportunity: Creating personalized and engaging campaigns that motivate diabetes patients to seek professional help and not ignore their difficulties.
Industry Implications
1. Healthcare - Disruptive innovation opportunity: Integrating technology and medical advancements to develop innovative approaches for diagnosing and treating chronic nerve pain in diabetes patients.
2. Advertising - Disruptive innovation opportunity: Utilizing data-driven targeting and social media influencers to create impactful and persuasive diabetes awareness campaigns.
3. Pharmaceuticals - Disruptive innovation opportunity: Researching and developing new medications and therapies to specifically target and alleviate chronic nerve pain in diabetes patients.